Clinical Profile, Adverse Drug Reaction, and Outcome of Category V Patients at a Drug-resistant Tuberculosis Center, Mumbai-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Profile, Adverse Drug Reaction, and Outcome of Category V Patients at a Drug-resistant Tuberculosis Center, Mumbai

Published:2022-07-08 Issue:2 Volume:64 Page:65-67
ISSN:0377-9343
Container-title:The Indian Journal of Chest Diseases and Allied Sciences
language:en
Short-container-title:

Author:

Desai Unnati,Joshi Jyotsna M,Thakare Parikshit,Utpat Ketaki

Publisher

Jaypee Brothers Medical Publishing

Subject

General Medicine

Link

https://www.ijcdas.com/doi/pdf/10.5005/jp-journals-11007-0001

Reference19 articles.

1. 1. World Health Organization. Multidrug and extensively drug-resistant TB. Geneva: World Health Organization; 2010.

2. 2. Sharma S, Kumar S, Saha P, et al. Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients. Indian J Med Res 2011;133:312–315. PMID: 21441686.

3. 3. Behera D. Drug resistant tuberculosis in India – is it a matter of concern? Indian J Tuber 2007;54(3):105–109. PMID: 17886697.

4. 4. Nathanson E, Gupta R, Huamani P, et al. Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J Tuberc Lung Dis 2004;8(11):1382–1384. PMID: 15581210.

5. 5. Drobniewski F, Eltringham I, Graham C, et al. A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax 2002;57(9):810–816. DOI: 10.1136/thorax.57.9.810.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP